Belpointe Asset Management LLC Akero Therapeutics, Inc. Transaction History

Belpointe Asset Management LLC

  • $1.51 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$33.44 - $54.8 $57,851 - $94,804
1,730 New
1,730 $94,000
Q4 2021

Feb 15, 2022
SELL
$19.87 - $26.24 $434,954 - $574,393
-21,890 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$18.65 - $25.46 $3,543 - $4,837
-190 Reduced 0.86%
21,890 $489,000
Q1 2021

May 14, 2021
BUY
$24.04 - $34.19 $530,803 - $754,915
22,080 New
22,080 $641,000

Others Institutions Holding AKRO

# of Institutions
210
Shares Held
74.3M
Call Options Held
321K
Put Options Held
558K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.1B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email